<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02727894</url>
  </required_header>
  <id_info>
    <org_study_id>00023001-2015</org_study_id>
    <nct_id>NCT02727894</nct_id>
  </id_info>
  <brief_title>Colorectal Cancer Study: Screening v.s. Other Diagnostics</brief_title>
  <acronym>CRC</acronym>
  <official_title>Colorectal Cancer Study: Screening v.s. Other Diagnostics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute for Clinical and Experimental Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Private practice at Hluboká nad Vltavou</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klaudian Hospital Mladá Boleslav</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Masaryk Hospital Rakovník</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medic Kral Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chomutov Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tomas Bata Hospital, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Military University Hospital, Prague</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Frýdek-Místek Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University Hospital Plzeň</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vitkovice Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institute for Clinical and Experimental Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether colorectal cancer diagnosed by screening
      (primary screening colonoscopy, colonoscopy after FOBT) has a better pTNM classification than
      colorectal cancer diagnosed byl other diagnostics (diagnostic colonocopy, CT, MR etc.).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentre prospective observational study. 12 centres across the Czech rep. included. Study
      approved by Ethical Committee. Informed consent signed by every patient. Study coordinator in
      each centre. Patient registry availble in every centre. Patient informations stored under ID
      in secured internet database (RedCap) run by ICRC (The International Clinical Research Center
      of St. Anne's University Hospital Brno). Statistical validation of data and analysis
      (descriptive statistics, two-sample T-Test, Mann-Whitney test, Fisher exact test and
      Chi-Square test).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Colorectal Cancer Stage (pTNM)</measure>
    <time_frame>Two years</time_frame>
    <description>Differences between colorectal cancer stage in screening vs. non-screening group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Colorectal Cancer Grade</measure>
    <time_frame>Two years</time_frame>
    <description>Differences between colorectal cancer grade in screening vs. non-screening group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal Cancer Resection Margins</measure>
    <time_frame>Two years</time_frame>
    <description>Difference between colorectal cancer resection margins (RX, R0, R1, R2) in screening vs. non-screening group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal Cancer Metastatis</measure>
    <time_frame>Two years</time_frame>
    <description>Differences between occurrence of colorectal cancer metastasis (MX, M0, M1) between screening vs. non-screening group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal Cancer Surgery</measure>
    <time_frame>Two years</time_frame>
    <description>Mean time between diagnosis and surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colorectal Cancer Paliative Therapy</measure>
    <time_frame>Two years</time_frame>
    <description>Differences between neoadjuvant, adjuvant and systemic paliative therapy in screening vs. non-screening group.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Colorectal Cancer Localization</measure>
    <time_frame>Two years</time_frame>
    <description>Differences between localization of colorectal cancer in screening vs. non-screening group.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">276</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Screening</arm_group_label>
    <description>Patients with colorectal cancer diagnosed by screening procedures (primary screening colonoscopy, colonoscopy after FOBT).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Others</arm_group_label>
    <description>Patients with colorectal cancer diagnosed by other diagnostic procedures (diagnostic colonoscopy, CT, MR, USG, urgent surgery, etc.)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinics, university hospitals, private practices
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  newly diagnosed colorectal cancer

        Exclusion Criteria:

          -  unsigned informed consent

          -  mental disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Král, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Clinical and Experimental Medicine</affiliation>
  </overall_official>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2016</study_first_submitted>
  <study_first_submitted_qc>March 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2016</study_first_posted>
  <last_update_submitted>March 30, 2016</last_update_submitted>
  <last_update_submitted_qc>March 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institute for Clinical and Experimental Medicine</investigator_affiliation>
    <investigator_full_name>Jan Král, MD</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Screening</keyword>
  <keyword>pTNM</keyword>
  <keyword>Metastasis</keyword>
  <keyword>Chemotherapy</keyword>
  <keyword>Resection Margins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be shared after publication in journal. End of 2016.</ipd_description>
  </patient_data>
  <pending_results>
    <submitted>August 19, 2017</submitted>
    <returned>February 27, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

